[1] 王少为,李旻,褚德发,等. 妊娠早期合并临床或亚临床甲状腺功能减退症和甲状腺自身抗体阳性与早产发生风险的荟萃分析[J].中华妇产科杂志, 2014, 49(11): 816-822. [2] Thangaratinam S, Tan A, Knox E,et al. Association between thyroid auto antibodies and miscarriage and preterm birth: meta-analysis of evidence[J].BMJ,2011, 342:d2616. [3] 丁榕,范建霞.美国甲状腺学会《2017年妊娠及产后甲状腺疾病诊治指南》解读[J].中华围产医学杂志,2017,20(3):165-168. [4] 单忠艳,腾卫平. 妊娠期甲状腺疾病诊治的争议热点[J].中华内科杂志,2017,56(1):1-3. [5] Baloch Z, Carayon P, Conte-devolx B, et al. Laboratory medicine practice guidelines.Laboratory support for the diagnosis and monitoring of thyroid disease [J].Thyroid,2003, 13 (1):123-126. [6] 中华医学会内分泌学分会,中华医学会围产医学分会.妊娠和产后甲状腺疾病诊治指南[J].中华内分泌代谢杂志,2012,28(5):354-371. [7] 黄璐,罗丹,王利民,等.成都地区妊娠期特异性甲状腺水平参考值范围的探讨及临床分析[J].现代妇产科进展,2016,4(25):269-272. [8] 王淑贞,刘杰,林丽娅.建立该地区妊娠各期甲状腺激素参考范围及甲状腺激素变化的探讨[J].中外医疗,2016,35(12):61-68. [9] Bestwick JP, John R, Maina A, et al. Thyroid stimulating hormone and free thyroxine in pregnancy: expressing concentrations as multiples of the median (MoMs) [J].Clin Chim Acta,2014,430:33-37.
2018, Vol. 35 
